Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British pharmaceutical company. The Financial Times reported this on Friday that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback